47 | Ibrutinib and Rituximab is Superior to Immunochemotherapy in Previously Untreated Mantle Cell Lymphoma Despite Lower Rates of Mrd Negativity
No Thumbnail Available
All Authors
Lewis,D.
Burton,C.
Sorrell,L.
Jerkeman,M.
Glimelius,I.
Poulsen,C.
Pasanen,A.
Wader,K.
Morley,N.
Davies,A.
LTHT Author
Burton, Cathy
Dalal, Surita
de Tute, Ruth
Dalal, Surita
de Tute, Ruth
LTHT Department
Oncology
Haematology
Leeds Cancer Centre
Haematological Malignancy Diagnostic Service
Haematology
Leeds Cancer Centre
Haematological Malignancy Diagnostic Service
Non Medic
Consultant Clinical Scientist Lead
Publication Date
2025
Item Type
Article
Language
Subject
Subject Headings
Abstract
Journal
Hematological oncology